The stock of Sight Sciences Inc (NASDAQ: SGHT) has increased by 10.23 when compared to last closing price of 5.28.Despite this, the company has seen a gain of 8.38% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-18 that MENLO PARK, Calif., April 18, 2024 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, today announced it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 2, 2024. The Company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Is It Worth Investing in Sight Sciences Inc (NASDAQ: SGHT) Right Now?
The 36-month beta value for SGHT is also noteworthy at 2.78. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for SGHT is 26.52M, and at present, short sellers hold a 4.74% of that float. The average trading volume of SGHT on April 30, 2024 was 173.44K shares.
SGHT’s Market Performance
SGHT’s stock has seen a 8.38% increase for the week, with a 10.23% rise in the past month and a 23.57% gain in the past quarter. The volatility ratio for the week is 10.43%, and the volatility levels for the past 30 days are at 9.14% for Sight Sciences Inc The simple moving average for the past 20 days is 5.84% for SGHT’s stock, with a 22.77% simple moving average for the past 200 days.
Analysts’ Opinion of SGHT
Piper Sandler, on the other hand, stated in their research note that they expect to see SGHT reach a price target of $5.50, previously predicting the price at $15. The rating they have provided for SGHT stocks is “Neutral” according to the report published on September 12th, 2023.
BofA Securities gave a rating of “Underperform” to SGHT, setting the target price at $4.50 in the report published on September 12th of the previous year.
SGHT Trading at 17.69% from the 50-Day Moving Average
After a stumble in the market that brought SGHT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.04% of loss for the given period.
Volatility was left at 9.14%, however, over the last 30 days, the volatility rate increased by 10.43%, as shares surge +9.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +36.94% upper at present.
During the last 5 trading sessions, SGHT rose by +8.38%, which changed the moving average for the period of 200-days by -25.38% in comparison to the 20-day moving average, which settled at $5.52. In addition, Sight Sciences Inc saw 12.79% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SGHT starting from Badawi Paul, who sale 12,571 shares at the price of $5.08 back on Apr 03 ’24. After this action, Badawi Paul now owns 5,750,729 shares of Sight Sciences Inc, valued at $63,848 using the latest closing price.
Bauerlein Alison, the Chief Financial Officer of Sight Sciences Inc, sale 10,123 shares at $5.08 during a trade that took place back on Apr 03 ’24, which means that Bauerlein Alison is holding 426,248 shares at $51,415 based on the most recent closing price.
Stock Fundamentals for SGHT
Current profitability levels for the company are sitting at:
- -0.71 for the present operating margin
- 0.85 for the gross margin
The net margin for Sight Sciences Inc stands at -0.69. The total capital return value is set at -0.37. Equity return is now at value -39.64, with -29.26 for asset returns.
Based on Sight Sciences Inc (SGHT), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at -1.37. The debt to equity ratio resting at 0.29. The interest coverage ratio of the stock is -10.59.
Currently, EBITDA for the company is -56.66 million with net debt to EBITDA at 1.99. When we switch over and look at the enterprise to sales, we see a ratio of 2.29. The receivables turnover for the company is 5.67for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 13.29.
Conclusion
In summary, Sight Sciences Inc (SGHT) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
